Skip to main content
メニュー
JP

Resource Center

Filters
Select resource types
Select products & services
Select solutions (2)
Active Filters (2)
Clear All
157 - 168 of 185 Results
Sort by: Best Match
Best Match
Title A-Z
Title Z-A
Filter & Sort
Infographic Icon   Infographic
Addressing the challenges in modern biotherapeutic development
Explore next-generation approaches to enable the development and characterization of bispecific and multi-specific antibodies
Product Note Icon   Product Note
Automated characterization of proteins and nucleic acids
Streamline your slab gel electrophoresis, while providing increased throughput and the data formats required for biotherapeutics and genomics workflows.
Application Note Icon   Application Note
Increase bacterial species detection in microbiome stool samples
Performance comparison study of CRISPRclean® Plus and Illumina® Ribo-Zero™ Plus for microbiome analysis
Publication Icon   Literature - Publication Review
Current approaches to identify possible COVID-19 therapeutics
Current approaches to identify possible COVID-19 treatment strategies fall into one of three categories: Antivirals, antibodies, or protein-protein interaction inhibitors.
Whitepaper Icon   Whitepaper
An emerging therapeutic modality - RNA carves its path out of the paradigm
Learn more about several promising classes of RNA therapeutic, including RNAi, CRISPR, base editing, and mRNA vaccines, as well as the potential to combine RNA technologies with CAR-T.
Application Note Icon   Application Note
Protocol optimization for detection and quantification of membrane-bound proteins using AlphaLISA technology
AlphaLISA kits have the capability to assess hundreds of targets, including cytokines, proteins circulating in the blood, and cellular proteins.
Brochure Icon   Brochure
Biologics workflow solutions
Revvity can help you discover and develop high-quality biological drug products by streamlining the biologics workflow.
Whitepaper Icon   Whitepaper
Addressing the challenges of bispecific antibody characterization with high-throughput platforms
With the complexities of bispecific antibody development and characterization explore the binding assays and technology through real-world examples
Whitepaper Icon   Whitepaper
Exploring the strengths, challenges, and therapeutic applications of multispecific antibodies
Discover the latest advancements in multispecific antibodies and their transformative potential in treating complex diseases. Download our comprehensive white paper now!
Application Note Icon   Application Note
Rapid, no-wash measurement of immune checkpoint molecules and cytokines in co-cultures of immune cells and cancer cell lines
Download this application note to learn how to rapidly measure multiple biomarkers in cell culture supernatant and lysates
Application Note Icon   Application Note
Biochemical binding ADCC assays utilizing AlphaLISA toolbox reagents for the characterization of hIgGs and FcγR1A
In this application note we demonstrate the ease with which AlphaLISA toolbox reagents can be used to develop any FcγR binding assay across the various stages of biologics research and development, including therapeutic screening and GMP Lot Release.
Application Note Icon   Application Note
Simultaneous detection of drug efficacy and toxicity by combining HTRF, AlphaLISA, or AlphaLISA SureFire Ultra with ATPlite
This application note demonstrates how compound’s mechanism of action and potential cytotoxic effects can be deciphered thanks to the combination of AlphaLISA™, HTRF™ or AlphaLISA™ SureFire® Ultra™ immunoassays with ATPlite™ 1step cell viability assay.
resource-center-page-end-card-bg-illuminator.png
resource-center-page-end-card-bg-illuminator-mobile.png

Looking for technical documents?

Find the technical documents you need, ASAP, in our easy-to-search library.